James E. Fickenscher, Chief Financial Officer at AUXILIUM PHARMACEUTICALS INC (AUXL), bought 1,000 shares at $6.43 ($6K) on 2006-03-10, disclosed to the SEC on 2006-03-14.
Open-market purchase of $6k AUXL by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ZYNE | SELL | 2022-07-20 | $7K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |